All lobbying filings

BECTON, DICKINSON AND COMPANY

BECTON, DICKINSON AND COMPANY filed a Q3 report for BECTON DICKINSON AND COMPANY on October 20, 2026.

Lobbying for BECTON DICKINSON AND COMPANY

All filings by BECTON, DICKINSON AND COMPANY · Everything BECTON DICKINSON AND COMPANY has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Expenses

$390,000

What this organization spent lobbying with its own staff. Reported using IRS section 162(e) definitions (method C): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 10

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 5

Health Issues

Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to maternal health

Taxation/Internal Revenue Code

Issues related to corporate taxation Tax incentives for domestic manufacturing

Budget/Appropriations

Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to the National Defense Authorization Act

Trade (domestic/foreign)

Issues related to international trade Issues related to medical device supply chain & Section 232 National Security Investigation into medical devices, and USMCA and Section 301 Investigations

Medicare/Medicaid

Issues related to reimbursement Issues related to CY2026 Home Health and DMEPOS PPS final rule and ANPRM on PPE and essential medicines

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.